Introduction {#bhz055s1}
============

GABA is the principal inhibitory neurotransmitter in the central nervous system (CNS) with manifold functions: it regulates action potential (AP) firing and network synchrony through perisomatic inhibition and the efficacy and plasticity of excitation by dendritic inhibition ([@bhz055C35]; [@bhz055C26]; [@bhz055C25]). GABA signaling can be either short-lived and phasic when GABA is released *in quanta* to act at synaptic GABA~A~ receptors or long-lasting and tonic upon ambient extracellular GABA stimulating extra-synaptic receptors ([@bhz055C28]). In addition, GABA affects developmentally coded cortical critical period plasticity by modulating interneuron migration, placement and synaptic wiring ([@bhz055C2]). Indeed, at the systems level, GABA signaling underpins learning, memory, cognition and sensory perception ([@bhz055C10]). The life-long competence of GABA signaling relies on efficient local means for neurotransmitter reuptake, replenishment and release. Considering the prominence of dysfunctional GABA signaling in brain disorders, such as epilepsy, autism, schizophrenia and anxiety ([@bhz055C51]; [@bhz055C37]), it is surprising that molecular determinants rate-limiting precursor availability for metabolic replenishment and vesicular filling and their impact on inhibitory synaptic plasticity remain elusive.

To describe precursor replenishment, the "glutamate/GABA-glutamine (GGG) cycle" was proposed decades ago, which suggests that GABA (and glutamate) upon transport into perisynaptic astroglia is first converted into glutamine, which is then transported back into neurons to regenerate GABA as neurotransmitter ([@bhz055C48]; [@bhz055C42]). This is supported by elucidation of the unconventional kinetics combined with the cell-specific localization of a family of amino acid (AA) transporters (Slc38) ([@bhz055C42]): system N transporters Slc38a3 (SN1/SNAT3) and Slc38a5 (SN2/SNAT5) reside on astroglial membranes and work bi-directionally to supply neurons with glutamine ([@bhz055C14]; [@bhz055C21]). Heterologous expression of the homologous system A transporter (SAT) Slc38a1 (SAT1/SNAT1/SA2) in cultured mammalian cells shows transport of amino acids with a preference for glutamine ([@bhz055C55]; [@bhz055C15]). We have shown that Slc38a1 is enriched in GABAergic neurons and based on this localization proposed that Slc38a1 could be involved in the replenishment of the neurotransmitter GABA ([@bhz055C52]). However, this has been contested by a number of papers reporting that Slc38a1 occurs indiscriminately in glutamatergic, GABAergic, cholinergic and dopaminergic neurons and targeted primarily to their somatodendritic compartments implicating a broader role in general cellular metabolism ([@bhz055C39]; [@bhz055C16]). In addition, the functional significance of glutamine in GABA replenishment and the existence of a GGG cycle remain ambiguous since some studies have shown unchanged neurotransmission upon pharmacological inhibition of system A transporters, inactivation of phosphate-activated glutaminase (PAG) and/or removal of external glutamine ([@bhz055C40]; [@bhz055C32]). Thus, conclusive experimental evidence for the function of Slc38a1 *in vivo* and its impact on inhibitory synaptic plasticity, and the molecular determinants of GABA replenishment and GABAergic vesicular load are lacking, and more broadly, for the existence of a GGG cycle.

Here, we have genetically inactivated Slc38a1 in mice and characterized their phenotype at successive levels of cellular and network complexity *in vitro* and *in vivo*. We demonstrate that Slc38a1 sustains replenishment of GABA, impacts vesicle morphology and neurotransmitter content, triggers AP generation and regulates inhibitory synaptic plasticity *in vivo*.

Materials and Methods {#bhz055s2}
=====================

Animal Handling {#bhz055s3}
---------------

Experiments were approved and conducted in accordance with the Norwegian Animal Welfare Act and the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (ETS 123). The mice were kept and handled under veterinary supervision at the UiO. Mice were housed in a temperature controlled facility (22--26 °C) with 50 ± 10% humidity and a 12-hours light/dark cycle. Animals were served municipal water and fed ad libitum with RM3 (E) from Special Diets Services (UK).

Discharge/frequency experiments on animals were performed at Karolinska Institutet and conformed to the European Communities Council Directive (86/609/EEC) and were approved by the Stockholms Norra Djurförsöksetiska Nämnd (N26/2005 and N38/2005).

Generation of a floxed Slc38a1 Mouse {#bhz055s4}
------------------------------------

The floxed Slc38a1 targeting construct was produced (Fig. [1](#bhz055F1){ref-type="fig"}*A*) using recombineering techniques ([@bhz055C38]). A 12 904 bp genomic DNA fragment containing exons 5--12 of the Slc38a1 gene was retrieved from BAC clone RP23-85D13. A LoxP sequence was inserted in intron 4 and a FRT-PGKNeo-FRT-LoxP cassette was inserted in intron 8. Thus, a fragment of 4504 bp genomic DNA containing exons 5 through 8 was floxed. Cre excision would generate an out-of-frame deletion. The targeting vector was electroporated into D1 embryonic stem (ES) cells which were derived from F1 hybrid blastocyst of 129S6 × C57BL/6 J. G418 resistant ES colonies were isolated and screened by nested polymerase chain reaction (PCR) using primers outside the construct paired with primers inside the neo cassette. Fourteen clones PCR positive for both arms were identified from 48 clones screened. Chimeric mice were generated by aggregating the ES cells with 8-cell embryos of CD-1 strain. The neo cassette was removed by mating the chimeras with 129S4/SvJaeSor-*Gt(ROSA)26Sor*^*tm1(FLP1)Dym*^/J (Stock number: 003946) homozygous females. The F1 pups were genotyped by PCR using primers flanking LoxP or FRT-LoxP sites. The mice were then crossed with Deleter mice to create a systemic deletion of Slc38a1 ([@bhz055C49]). As Slc38a1 expression is restricted to some few organs ([@bhz055C15]), secondary effects on the CNS phenotype is not very likely. Null mutant (Slc38a1^−/−^) mice did not carry any obvious phenotypic abnormalities. We had several breedings (het x het, ko x ko, wt x wt) and all were backcrossed between 5 and 10 times. In addition, the mice were crossed with wt mice regularly in order to avoid inbreeding of the mice in order to reduce the risk of differences in the genetic background.

![Genetic inactivation of Slc38a1 using the binary Cre/LoxP system and its validation. (*A*) Schematic drawing of the targeting vector, wild-type allele (Slc38a1^wt^ (Slc38a1^+^)), and targeted alleles (Slc38a1^flox-Neo^, Slc38a1^flox^, and Slc38a1^null^ (Slc38a1^-^)). The Slc38a1 targeting vector contained a LoxP site (inserted into intron 4; white triangles), and a selection cassette (Neomycin) flanked by FRT-sites (black triangles) and a LoxP site (inserted into intron 8). After homologous recombination in ES cells (Slc38a1^flox-Neo^ locus), ES cells were transected with Flp to excise the selection cassette (Slc38a1^flox^ locus) prior to blastocyst injection. Upon expression of Cre recombinase, exons 5--8 were excised (Slc38a1 null), generating out of reading frame splicing transcript. The binding site for the 5-end Southern screening probe and the expected fragment sizes after KpnI digest are indicated. (*B*) Genotyping of ear biopsies of Slc38a1^+/+^, Slc38a1^+/-^ (heterozygous) and Slc38a1^−/−^ mice by 3 pairs of probes gives the expected amplified fragments (see [Supplementary Experimental Procedures](#sup1){ref-type="supplementary-material"}). (*C*) Southern blot analysis of DNA isolated from liver of Slc38a1^+/+^, Slc38a1^+/−^, and Slc38a1^−/−^ mice. DNA was digested with KpnI followed by hybridization with the 5-probe to give the expected fragments for Slc38a1^WT^ (20.2 kb) and Slc38a1^Null^ (15.7 kb). (*D*) Expression of Slc38a1 protein in brain lysates of Slc38a1^+/+^, Slc38a1^+/−^, and Slc38a1^−/−^ mice was investigated. No protein expression is detected in lysates from Slc38a1^−/−^ mice, while Slc38a1^+/-^ mice show reduced staining for Slc38a1 protein compared to Slc38a1^+/+^ mice. β-actin was used as loading control. E) Expression of Slc38a1 protein was investigated by immunostaining of free-floating brain sections for Slc38a1. In the hippocampus, Slc38a1 immunoreactivity accumulates in scattered interneuron-like cells in the CA1 and dentate area of Slc38a1^+/+^ mice. Such staining is abolished in sections from Slc38a1^−/−^ mice. G, granulare; LM, lacunosum-moleculare; M, moleculare; P, pyramidale; R, Radiatum. Insets: P, pyramidal cells; I, interneuron-like cell. Scale: 100 μm.](bhz055f01){#bhz055F1}

A new set of primers were designed for PCR genotyping. The template DNA was obtained by digesting an ear piece using the REDExtract-N-Amp™ Tissue PCR Kit (Sigma) followed by PCR-amplification of 1 μl of the template in a 10 μl PCR reaction. The reaction was carried out for 35 cycles (94 °C 30 s, 60 °C 30 s and 72 °C 30 s) followed by one cycle of 72 °C for 10 min.

Primers Used for Generation of a Floxed Slc38a1 Mice and for Investigating Their Genotypes {#bhz055s5}
------------------------------------------------------------------------------------------

The homologous arms were 2945 bp (5′) and 5440 bp (3′). Primer sequences for ES screening were: 5′ arm forward primers: Slc38a1 Scr F1 (5′- cgtgttctccgtcagctatt-3′) and Slc38a1 Scr F2 (5′- atgtccggcagagtctttga-3′). Reverse primers: LoxP Scr R1 (5′-gagggacctaataacttcgt-3′) and LoxP Scr R2 (5′-ggaattgggctgcaggaatt-3′). 3′ arm forward primers: FRT Scr F1 (5′-ttctgaggcggaaagaacca-3′) and FRT Scr F2 (5′-cgaagttattaggtggatcc-3′); Reverse primers: Slc38a1 Scr R1 (5′-agtgatggtaaccgtcctgt-3′) and Slc38a1 Scr R2 (5′-ctactggccaggaacaacgat-3′).

A new set of primers were designed for PCR genotyping. The primer combination Scl38a1-Scr1: (5′-tgtaggtctgttcccatgttgtcct-3′) and Scl38a1-Scr2: (5′-gatgaaatgttccccggagtctaac-3′) generates a PCR product of 426 bp for the wild type allele, and 514 bp for the floxed allele. The primer set Scl38a1-scr3 (5′-tctcccactaagttgcgttgtcttc-3′) and Scl38a1-scr4(5′-ccaaatggatgacttggagattgtc-3′) generates a PCR product of 372 bp for the wild type allele and 471 bp for the floxed allele. Detection of the null allele after Cre excision was detected using the primer combination Scl38a1-Scr1 and Scl38a1-Scr4 giving a PCR product of 616 bp for the null allele and a fragment too large to be amplified for the wild type allele.

Southern Blotting {#bhz055s6}
-----------------

The probe sequence was radiolabelled with \[a-32P\]dCTP (Perkin Elmer, Wellesley, MA) using Megaprime DNA labelling System (Amersham Biosciences) prior to hybridization of the membrane to verify homologous recombination of the loci in the animals.

Synaptosomes, Amino Acid Analysis, and Quantitative Western Blotting {#bhz055s7}
--------------------------------------------------------------------

Synaptosomes were made by homogenization of the brains in ice cold 0.32 M sucrose 5% (w/v) followed by several steps of ultracentrifugation, as described ([@bhz055C5]). Synaptosomal amino acids were separated and quantified by HPLC and fluorescence detection after pre-column derivatization with o-phthaldialdehyde ([@bhz055C22]). Western blot analyses were performed as described ([@bhz055C43]). For details, see SI.

Light- and Electron Microscopic Cytochemistry {#bhz055s8}
---------------------------------------------

Ten pairs of age- and sex-matched Slc38a1^+/+^ and Slc38a1^−/−^ mice were deeply anesthetized with intra-peritoneal injection of Zoletil-mix 125 mg/kg. Five of the pairs were fixed by transcardiac perfusion of 4% paraformaldehyde (PFA) for immuneperoxidase staining and 5 pairs were perfusion fixed with 4% PFA and 2.5% glutaraldehyde (GA), hippocampal CA1 regions dissected out, embedded in Durcupan (FLUKA), sectioned (\~100 nm), immunogold labeled and analyzed by Electron microscopy, as described (SI; [@bhz055C30]; [@bhz055C52]).

Antibodies {#bhz055s9}
----------

Antibodies were generated against the most divergent and antigenic regions of the members of the Slc38 family of amino acid/glutamine transporters, Slc17 family of vesicular glutamate transporters and Slc32 family of vesicular GABA transporter by subcloning these sequences C-terminal to the sequence for glutathione-S-transferase (GST), inducing the protein in Escherichia coli and immunizing 2--6 rabbits for each protein. The antiserum obtained has been vigorously affinity purified by absorbing against immobilized GST followed by isolating on a column with immobilized GST-fusion protein containing the antigenic peptide used to immunize rabbits. These antibodies have then been properly characterized in our previous publications (e.g., [@bhz055C13]; [@bhz055C7]; [@bhz055C6]; [@bhz055C30]; [@bhz055C52]; [@bhz055C21]). Antibodies against AAs were generated by conjugating Bovine Serum Albumin (BSA) to the AAs by glutaraldehyde. The BSA-conjugates were separated by dialysis and mixed with adjuvant and injected intracutaneously in rabbits. Please, see detailed information on the procedure ([@bhz055C44]) and the characterization of some of the antibodies in our previous publications ([@bhz055C30]; [@bhz055C52]). Commercial antibodies against other proteins were used according to recommendations from the companies. Goat anti-rabbit and anti-mouse IgG Horseradish Peroxidase for western blotting (Thermo Fischer Scientific) and the biotin-streptavidin-peroxidase system and DAB were used as described earlier ([@bhz055C30]; [@bhz055C52]). Commercial antibodies against other proteins were only used if they showed right band on western blots and had been characterized and published elsewhere. They were used according to recommendations from the companies.

Extracellular Recordings {#bhz055s10}
------------------------

Extracellular recordings were performed on 400 μm thick hippocampal slices prepared from adult (\>P60) from Slc38a1^+/+^ and Slc38a1^−/−^ mice. Data are presented as mean ± S.E.M. Statistical significance was evaluated by using a linear mixed model analysis (SAS 9.1), with *P* \< 0.05 being designated as statistically significant. See SI for details.

Interneuron studies {#bhz055s11}
-------------------

Isolation of interneurons and their analyses were performed according to ([@bhz055C3]). For details, see SI.

Monocular Deprivation and In vivo Electrophysiology {#bhz055s12}
---------------------------------------------------

Extracellular recordings of single unit activity and local field potentials were made using linear silicone probes with 16 recording sites spaced at 50 μm intervals (NeuroNexus probes, A1x16-3 mm-50-177). Craniotomies to expose the primary visual cortex (2 mm in diameter, 1 mm anterior and 3 mm lateral to lambda) were made above one (contralateral to the deprived eye in MD animals or both hemispheres (control animals). The electrode was lowered into the brain to a depth of 1000 μm in the V1B, and was allowed to settle for 20 min before recording. Electrophysiological recordings were performed under light isoflurane anesthesia (0.5--1%) supplemented with intramuscular administration of chlorprothixene (0.2 mg). Visual stimuli was generated using Psychophysics Toolbox extension ([@bhz055C8]) for MATLAB (Mathworks) and sinusiodal drifting gratings were displayed on a 21" computer monitor centered 25 cm in front of the animal. Four days of MD was started between postnatal day 25 (P25) and P27. Eyelids were sutured shut under isoflurane anesthesia.

### Statistical Analysis {#bhz055s13}

All values are presented as mean ± SEM. All data were analyzed by linear mixed models followed by comparisons of least square means. Statistical tests were performed in R.

Results {#bhz055s14}
=======

Genetic Inactivation of Slc38a1 Abolishes Interneuron-Like Localization {#bhz055s15}
-----------------------------------------------------------------------

In order to examine the potential involvement of Slc38a1 in GABA replenishment and synaptic plasticity *in vivo*, we used the binary Cre/LoxP system to genetically inactivate Slc38a1 in mice by deleting exons 5--8 (Fig. [1](#bhz055F1){ref-type="fig"}*A*). Genetic identity was confirmed by PCR using 3 pairs of primers and by Southern blotting (Fig. [1](#bhz055F1){ref-type="fig"}*B*--*C*). The genotypes were further corroborated by analyses of RNA transcripts (not shown) and Slc38a1 protein expression by Western blotting showing no expression of the protein in Slc38a1^−/−^ mice (Fig. [1](#bhz055F1){ref-type="fig"}*D*). In brain, overall cell numbers and cortical cytoarchitecture were identical in both genotypes ([Fig. S1*A*--*F*](#sup1){ref-type="supplementary-material"}). Immunoperoxidase staining for Slc38a1 accumulates in scattered interneuron-like cells in Slc38a1^+/+^ mice while it is entirely abolished in brain sections from Slc38a1^−/−^ mice (Fig. [1](#bhz055F1){ref-type="fig"}*E*, [S1*G*--*J*](#sup1){ref-type="supplementary-material"}). Thus, DNA, RNA and protein analyses confirm successful inactivation of Slc38a1 in mice, and exclude major phenotypic abnormalities for brain anatomy. Moreover, these data points to Slc38a1 as specific for neurons with interneuron-like layer distribution.

Slc38a1 Inactivation Alters Levels of Key AAs and Enzymes Involved in GABA Synthesis {#bhz055s16}
------------------------------------------------------------------------------------

We next investigated the functional significance of Slc38a1-mediated glutamine transport for the metabolic and/or neurotransmitter pools of several AAs. Analyses of forebrain extracts obtained from Slc38a1^+/+^ and Slc38a1^−/−^ mice show significantly reduced levels of AAs associated with the GABA metabolism and the GGG cycle, i.e., glutamine, glutamate, GABA and aspartate (Fig. [2](#bhz055F2){ref-type="fig"}*A*). In contrast, other AAs, such as alanine, serine, glycine, and taurine, remained unchanged upon Slc38a1 inactivation (Fig. [2](#bhz055F2){ref-type="fig"}*A*). These data implicate a role for Slc38a1 in the replenishment of AAs potentially involved in GABAergic neurotransmission *in vivo*.

![Slc38a1 inactivation reduces selectively levels of amino acids (AA) and increases levels of proteins sustaining GABA transmission. (*A*) The concentration of AAs in forebrains of Slc38a1^−/−^ (red) and Slc38a1^+/+^ (black) mice (*n* = 5 in each group) were investigated by HPLC. Significant reduction in the levels of glutamine (Gln), glutamate (Glu), GABA and aspartate (Asp) was detected upon Slc38a1 inactivation. The levels of some other AAs, such as alanine (Ala), serine (Ser), glycine (Gly) or taurine (Tau), were not altered. (*B*) Synaptosomes were made from brains of Slc38a1^−/−^ (red) and Slc38a1^+/+^ (black) mice and their content of AAs was measured by HPLC: Glutamine and aspartate are significantly reduced. Glutamate and GABA are sub-significantly reduced, while there is no difference in the concentrations of taurine in Slc38a1^−/−^ compared to Slc38a1^+/+^. (*C*) Quantitative immunoblotting of total brain extracts from Slc38a1^−/−^ and Slc38a1^+/+^ mice shows significant up-regulation of GAD67 and PAG in Slc38a1^−/−^ mice compared to Slc38a1^+/+^ mice. Proteins associated with glutamatergic neurotransmission, such as NR2B and VGLUT1, are not increased. GAD67, Glutamic acid decarboxylate (GAD) 67 kDa; PAG, (kidney) Phosphate-activated glutaminase; Slc38a2, Slc38 family member 2: The System A transporter 2 (SAT2/SNAT2); GS, Glutamine synthetase; GABA-T, GABA aminotransferase; GAD65, GAD 65 kDa; Rab3a, The RAS-related protein 3 A; GABA~A~R, GABA~A~ receptor; EAAT3, Excitatory amino acid transporter (EAAT) 3 (Slc1a1); EAAT1 (Slc1a3); SNAP25, Synaptosomal-associated protein 25; GAT1, GABA transporter 1 (Slc6a1); EAAT2 (Slc1a2); Slc38a3, Slc38 family member 3: The System N transporter 1 (SN1/SNAT3); VGLUT2, Vesicular glutamate transporter (VGLUT) 2 (Slc17a6); VGAT, Vesicular GABA transporter (Slc32); VAMP, Vesicle- associated membrane protein; NR2B, NR2B subunit of NMDA receptor; VGLUT1 (Slc17a7). Red and black bars in A and B: Slx38a1^−/−^ and Slx38a1^+/+^, respectively. Data are mean ± SD values. Asterisk: different from control; *P* \< 0.007 (A,C: unpaired Student's *t*-test, B: Mann--Whitney test).](bhz055f02){#bhz055F2}

Next, we assessed whether the reduced pools of AAs represented metabolic intermediates or neurotransmitters by analyzing synaptosomal fractions from Slc38a1^+/+^ and Slc38a1^−/−^ mice for AA content. Synaptosomes are suitable for first assessment of specialized neurotransmitter pools ([@bhz055C4]; [@bhz055C23]) although they are contaminated with gliosomes. We detected a significant reduction in synaptosomal glutamine and aspartate levels (Fig. [2](#bhz055F2){ref-type="fig"}*B*), the latter is formed downstream of GABA. In contrast, the GABA-homolog taurine---an osmolyte that does not participate in GABA metabolism or the GGG cycle---remains unchanged upon Slc38a1 inactivation (Fig. [2](#bhz055F2){ref-type="fig"}*B*).

As synaptosomal GABA levels are sub-significantly reduced, we hypothesized that Slc38a1 disruption activates compensatory mechanisms to maintain GABAergic neurotransmission. We therefore quantified key proteins involved in glutamate and GABA metabolism and signaling. Relative to wild-type (wt) littermates, Slc38a1^−/−^ mice showed significantly higher levels of GAD67, the enzyme catalyzing glutamate to GABA conversion (Fig. [2](#bhz055F2){ref-type="fig"}*C*). Likewise, the upstream enzyme, PAG, catalyzing glutamine to glutamate conversion, is up-regulated in Slc38a1^−/−^ mice (Fig. [2](#bhz055F2){ref-type="fig"}*C*). This suggests that GABA formation is distorted and that 2 key enzymes in the GABA synthesis pathway are up-regulated to overcome metabolic restrictions to maintain GABA (and its precursor glutamate) in nerve terminals. Expression of proteins contributing to the vesicular sequestration of GABA or glutamate, their receptors or plasma membrane transporters, remained unchanged. Altogether, our data suggest a selective role for Slc38a1 in GABA replenishment in harmony with its localization in interneurons (Fig. [1](#bhz055F1){ref-type="fig"}*E*, [S1*G*--*J*](#sup1){ref-type="supplementary-material"}).

Slc38a1 Deletion Alters Vesicle Morphology and Reduces Vesicular GABA Content {#bhz055s17}
-----------------------------------------------------------------------------

In order to reveal the impact of Slc38a1 on vesicular neurotransmitter content and synaptic transmission, we next studied synapse morphology and concentrations of the 2 main fast neurotransmitters and their putative precursor by electron microscopy. In the hippocampus, the number and morphological appearance of synapses, as well as subcellular structures were unchanged between Slc38a1^+/+^ and Slc38a1^−/−^ mice (Fig. [3](#bhz055F3){ref-type="fig"}*A* and *B*, [S2*A*](#sup1){ref-type="supplementary-material"}). Immunogold labeling of inhibitory nerve terminals (which represents the total vesicular and extra-vesicular concentration of the amino acids) of the hippocampal CA1 demonstrated significant reduction of glutamine and glutamate while GABA levels were sustained (Fig. [3](#bhz055F3){ref-type="fig"}*A*--*C*). This is congruous with a shift in the equilibrium to form GABA at the expense of its 2 precursors, glutamine and glutamate, and is consistent with our synaptosomal HPLC data and upregulated PAG and GAD67 expressions (Fig. [2](#bhz055F2){ref-type="fig"}). The selective role of Slc38a1 in GABAergic neurotransmitter replenishment is corroborated by a lack of any influence in adjacent glutamatergic nerve terminals since both glutamine and glutamate concentrations are preserved in Slc38a1^−/−^ mice (Fig. [3](#bhz055F3){ref-type="fig"}*D*).

![Slc38a1 inactivation alters synaptic vesicle morphology and GABAergic vesicular load. Pieces of hippocampal CA1 from Slc38a1^+/+^ and Slc38a1^−/−^ mice were dissected out, embedded in resins and examined by immunogold electron microscopy. (*A*--*B*) Two electron micrographs (from Slc38a1^+/+^ and Slc38a1^−/−^ mice, respectively) showing putative GABAergic nerve terminals making symmetric synapses onto pyramidal cell dendrites and stained for glutamine. Arrow heads demark synapses. (*C*) In GABAergic nerve terminals of the stratum radiatum, the immunoreactivities for glutamine and glutamate are significantly reduced while GABA levels are sustained in Slc38a1^−/−^ mice compared to Slc38a1^+/+^ mice. (*D*) Immunoreactivities for glutamine or glutamate in neighboring glutamatergic nerve terminals are not reduced upon deletion of Slc38a1. (*E*) The density of synaptic vesicles in putative GABAergic nerve terminals is increased in Slc38a1^−/−^ mice compared to Slc38a1^+/+^ mice. Such change in synaptic vesicle density is not seen in adjacent glutamatergic nerve terminals. (*F*) The circumference of synaptic vesicles in GABAergic and glutamatergic nerve terminals was measured. GABA^+^ synaptic vesicles had a small but significant reduction in the circumference in Slc38a1^−/−^ mice. The circumference of synaptic vesicles in glutamatergic nerve terminals withstood any changes upon genetic inactivation of Slc38a1. (*G*) The vesicular concentration of GABA and glutamate was assessed by measuring immunogold labeling of synaptic vesicles. Vesicular GABA is reduced in Slc38a1 knock-out mice compared to the wild type mice. No significant changes were detected for the vesicular glutamate concentration. (*H*) There is no significant change in the size of the postsynaptic density (PSD) at GABAergic synapses in Slc38a1^−/−^ mice compared to Slc38a1^+/+^ mice. Structures or staining related to GABAergic or glutamatergic synapses are shown in red and blue, respectively, while the black bars represent the corresponding structures or staining in wt mice. The numbers written on the bars indicate the number of structures analyzed. In E-H the percentage ratio between data obtained in Slc38a1^−/−^ and Slc38a1^+/+^ are shown. m, miotchondria; T, terminal. Asterisk: different from control; *P* \< 0.007, unpaired Student's *t*-test.](bhz055f03){#bhz055F3}

We then specifically focused on synaptic vesicles: the relative distribution of synaptic vesicles from the release site remains intact in Slc38a1^−/−^ mice ([Fig. S2*B*](#sup1){ref-type="supplementary-material"}). However, the density of synaptic vesicles in Slc38a1^−/−^ GABAergic terminals is increased (Fig. [3](#bhz055F3){ref-type="fig"}*E*; \~21% augmentment). In addition, there is a small, but significant reduction (in the circumference of GABAergic synaptic vesicles (Fig. [3](#bhz055F3){ref-type="fig"}*F*; \~8% reduction in volume). This is corroborated by immunogold labeling for GABA showing reduced vesicular content (Fig. [3](#bhz055F3){ref-type="fig"}*G*; \~16% GABA reduction). However, Slc38a1 inactivation was not associated with any significant change in the length of the post-synaptic density at GABAergic synapses (Fig. [3](#bhz055F3){ref-type="fig"}*H*) suggesting that Slc38a1^−/−^ synapses retain GABA signaling at near-physiological levels. Interestingly, Slc38a1 deletion has no impact on vesicle density, vesicle circumference or vesicular neurotransmitter content in glutamatergic nerve terminals (Fig. [3](#bhz055F3){ref-type="fig"}*E*--*G*) corroborating a selective impact on GABAergic neurotransmission. Thus, Slc38a1 disruption significantly reduces the specific vesicular GABA content.

Slc38a1^−/−^ Mice Retain Normal Excitatory Synaptic Transmission and Synaptic Plasticity {#bhz055s18}
----------------------------------------------------------------------------------------

To investigate any functional role for Slc38a1 in excitatory synaptic transmission and synaptic excitability, simultaneous electrophysiological recordings were conducted in the apical dendritic and soma layers in the CA1 region of hippocampal slices from Slc38a1^−/−^ and Slc38a1^+/+^ mice. We found no substantial differences in fiber density, number of afferent fibers, amount of excitatory synaptic transmission or excitability (Fig. [4](#bhz055F4){ref-type="fig"}*A*--*C*). Thus, these results do not support any major changes in either excitatory synaptic transmission or in postsynaptic excitability when tested by synaptic activation, and reconcile well with our electron microscopy data on glutamatergic synapses. A comparison of paired-pulse facilitation, a short-lasting form of synaptic plasticity primarily attributed to changes in presynaptic Ca^2+^ homeostasis ([@bhz055C57]), reveals no significant difference between the 2 genotypes (Fig. [4](#bhz055F4){ref-type="fig"}*D*). Finally, prolonged activation (20 Hz 50 s) of afferent fibers in the CA3-to-CA1 pathway or examination of LTP at hippocampal CA3-to-CA1 synapses in slices taken from adult mice showed no differences between the 2 genotypes (Fig. [4](#bhz055F4){ref-type="fig"}*E*--*G*). Altogether, our data do not show any major impact of Slc38a1 inactivation on glutamatergic synaptic transmission (See SI for detailed results).

![Normal hippocampal excitatory transmission and synaptic plasticity prevail in Slc38a1^−/−^ mice. Excitatory transmission and short- and long-term synaptic plasticity were investigated at hippocampal CA3-to-CA1 synapses. (*A*) There are no changes in stimulation strengths necessary to elicit a fiber volley of given amplitudes (0.5, 1.0 and 1.5 mV) in Slc38a1^−/−^ mice compared to wild type mice suggesting no difference in fiber density/number of afferents. (*B*) Field excitatory post-synaptic potential (fEPSP) amplitudes as a function of the same 3 fiber volley amplitudes are equal in the 2 genotypes suggesting normal excitatory synaptic transmission. (*C*) The fEPSP amplitudes necessary to elicit a just detectable population spike (1) and a population spike of 2 mV (2) are not altered suggesting no impact on pyramidal cell excitability. (*D*) No significant changes were detected in the paired-pulse facilitation (PPF) ratio in the 2 genotypes at an interstimulus interval of 50 ms. (*E*) Top row; each trace is the mean of 5 consecutive synaptic responses in stratum radiatum elicited by different stimulation strengths in slices from Slc38a1^+/+^ (left) and Slc38a1^−/−^ (right) mice. The prevolleys preceding the fEPSPs are indicated by circles. Bottom row; recordings from stratum pyramidale elicited by paired-pulse stimulation (50 ms interstimulus interval). Arrowheads indicate the population spike thresholds. (*F*) Normalized and pooled fEPSP slope measurements during the initial 30 seconds of 20 Hz stimulation in stratum radiatum in slices from Slc38a1^+/+^ and Slc38a1^−/−^ mice. Vertical bars indicate S.E.M. Subtractions of the values obtained in Slc38a1^+/+^ mice from those obtained in Slc38a1^−/−^ mice are represented by the black, open symbols. The inset graph shows *a* the time point of the maximum magnitude of the initial frequency facilitation (as indicated by an arrow in the figure), *b* time point to the transition point between the initial frequency facilitation and the delayed response enhancement (DRE), *c* time needed to reach the peak of the DRE. (*G*) Normalized, pooled and superimposed extracellular fEPSP slopes evoked at CA3--to-CA1 synapses in slices from Slc38a1^+/+^ and Slc38a1^−/−^ mice. Tetanized pathways are shown with circles and untetanized control pathways are shown with squares. Arrowhead indicates time point of tetanic stimulation. D, F and G suggest no major differences between the genotypes in some forms of short-term and long-term synaptic plasticity. Data are shown as mean ± standard error of mean (S.E.M). Experiments are shown with open symbols for Slc38a1^+/+^ mice and red, filled symbols for Slc38a1^−/−^. None of the comparisons between the genotypes were statistically significant (*P* \< 0.05).](bhz055f04){#bhz055F4}

Glutamine Discharges Perisomatic Interneurons {#bhz055s19}
---------------------------------------------

As Slc38a1 is preferentially expressed by hippocampal and cortical parvalbumin (PV)^+^ interneurons (also termed fast-spiking (FS) cells; Fig. [5](#bhz055F5){ref-type="fig"}*A*), we hypothesized that particularly efficacious means of GABA replenishment might have evolved to drive AP firing at high frequencies. Here, we pharmacologically probe Slc38a1-dependent glutamine uptake for GABA production and vesicular filling and correlate this with neuronal AP patterns. Besides *ex vivo* slice recordings, we developed a culture protocol to specifically enrich and maintain FS cells ([@bhz055C3]). We also used irregular-spiking (IR-like) interneurons with discharge frequencies \<50 Hz as controls.

![Glutamine induces high-frequency membrane oscillations in neocortical and hippocampal fast-spiking (FS) cells. (*A*) FS cells in CA1 stratum radiatum express the system A transporter Slc38a1. (*B*) Glutamine induces membrane depolarization of FS interneurons (*upper panel*) and generates an inward current (*bottom panel*; clamped at −70 mV), which are reversed upon wash-out. Red and blue dashed lines indicate resting membrane potentials at the start and end of current clamp recordings, respectively. (*C*) Current -- voltage relationship of SAT-mediated currents. Open squares refer to superfusion in control, while filled circles in the presence of glutamine (6 min). Note the glutamine-induced outward rectification. \**p* \< 0.05 vs. control (Student's *t*-test, *n* = 6). The reversal potential, conferring to the cross at the abscissa, did not change. (*D*) Representative current clamp record shows membrane potential oscillations induced by MeAIB and glutamine. Note that glutamine but not MeAIB alone depolarizes the recorded cell. E) Cultured FS-like cells were Slc38a1 immunoreactive at 12 days *in vitro*. Note Slc38a1 localization to varicose axon segments (E~1~). *Scale bars* = 30 μm (*E*), 4 μm (E~1~). (*F*) Glutamine-induced membrane potential depolarization is rapid in FS-like but less so in IR-like interneurons. 3-Mercaptopropionic acid (3-MPA) occludes this response. \**P* \< 0.05 *vs*. baseline at 0 min (Student's *t*-test). gray area denotes the 6-min period of glutamine superfusion. 3-MPA was applied for 16 h at 100 μM concentration. Data were expressed as means from *n* = 12--15 cells/condition. (*G*) Glutamine elicited a progressive increase in the frequency of membrane oscillations, which can transiently exceed 0 mV after glutamine application for 6 min with gradual repolarization upon wash-out. Vertical gray bars indicate the positions of high-resolution panels (a-d) in G~1~. Note the highly conserved time constant and amplitude of unitary Slc38a1-mediated conductance changes.](bhz055f05){#bhz055F5}

Glutamine uptake through SATs was previously reported to depolarize interneurons and to induce paired-pulse facilitation at inhibitory synapses in the hippocampus ([@bhz055C15]). Here, we first reproduced these findings by applying 5 mM glutamine (for lower concentrations, *data not shown*) that depolarized PV^+^ cortical interneurons (Fig. [5](#bhz055F5){ref-type="fig"}*A*--*B*). Glutamine transport through SATs relies on Na^+^ co-transport with maximal transporter efficacy at resting membrane potentials in the presence of high Na^+^ concentrations ([@bhz055C15]). Indeed, membrane depolarization was driven by an inward Na^+^ current with its reversal potential closely matching the calculated Na^+^ reversal potential (0 mV) when using 20 mM KCl intracellularly (Fig. [5](#bhz055F5){ref-type="fig"}*C*). Moreover, glutamine transport in FS cells showed significant outward rectification at \<−50 mV as opposed to a linear *I-V* relationship seen in control (Fig. [5](#bhz055F5){ref-type="fig"}*C*; [S3*B*](#sup1){ref-type="supplementary-material"}) and upon washout (*data not shown*) in the presence of 125 mM extracellular Na^+^ and pharmacologically-muted synaptic neurotransmission. Input resistance did not change during glutamine-induced depolarization, suggesting gating by intramembrane proteins without "*on-demand*" membrane insertion, and reversed upon wash-out ([Fig. S3*A*](#sup1){ref-type="supplementary-material"}). These data suggest that glutamine undergoes Na^+^-dependent electrogenic transport in FS cells through a mechanism operating well at deep resting membrane potentials, which corroborates data on transporter kinetics when Slc38a1 was expressed heterologously in Xenopus oocytes ([@bhz055C15]).

Previously, glutamine-induced depolarization was estimated as ≤ 5 mV ([@bhz055C15]) when measured at low temporal resolution. We reproduced these records at high sampling rates and using methyl aminoisobutyric acid (MeAIB) as SAT substrate to show an incremental (±3 mV) depolarization (Fig. [5](#bhz055F5){ref-type="fig"}*D*). However, when co-applying glutamine, we found a rapid membrane shift towards −40 mV (AP threshold for cultured FS cells ([@bhz055C3]), above which repetitive membrane oscillations with frequencies ranging from 1.8 to 2.5 Hz occurred (Fig. [5](#bhz055F5){ref-type="fig"}*D*). Glutamine-induced oscillations overshot 0 mV, thus qualifying as AP trains, and were long-lasting yet tended to decrease in frequency (Fig. [5](#bhz055F5){ref-type="fig"}*D*, end of trace). We attributed their gradual decline to metabolic strain on the neurons we probed. Moreover, both MeAIB and glutamine markedly increased the amplitude of spontaneous inhibitory postsynaptic currents (sIPSCs; 145.9 ± 9.8% and 180.3 ± 13.2% of the baseline, respectively; [Fig. S3*C*](#sup1){ref-type="supplementary-material"}) when measured in FS cells receiving significant recurrent inhibitory input from other FS cells in hippocampal CA1 ([@bhz055C20]). Thus, glutamine uptake through Slc38a1 might reset network excitability by driving FS cell activity.

We then exploited interneuron-enriched cultures ([@bhz055C3]) to dissect the electrogenic signature of glutamine uptake. In FS-like cells, which expressed Slc38a1 perisomatically as well as in processes (Fig. [5](#bhz055F5){ref-type="fig"}*E*, *E*~1~), current-clamp recordings showed that increasing the glutamine concentration from 2 to 5 mM extracellularly evoked robust depolarization (*P* \< 0.05 at 3 and 6 min *vs*. IR controls, *n* = 7/12; Fig. [5](#bhz055F5){ref-type="fig"}*F*). Discharge events were highly ordered, their frequency increased with ongoing glutamine superfusion (Fig. [5](#bhz055F5){ref-type="fig"}*G*), and reached steady-state by \~5 min of glutamine application when the raid surge in membrane potential is followed by a 1--2 s depolarization state and a subsequent rapid repolarization step (Fig. [5](#bhz055F5){ref-type="fig"}*G*~1~, *panel c*). Upon glutamine wash-out, both the frequency and amplitude of membrane depolarization gradually subsided. Pre-treatment with 100 μM 3-Mercaptopropionic acid (3-MPA), a GAD inhibitor, abolished glutamine-induced depolarization, suggesting end-point (product) regulation (Fig. [5](#bhz055F5){ref-type="fig"}*F*). These events were insensitive to AMPA, kainate or mGluR antagonists, excluding bias by glutamine-to-glutamate conversion ([Fig. S3*D*, *D*~1~](#sup1){ref-type="supplementary-material"}). Moreover, glutamine primes this phenomenon since step-wise depolarization fails to evoke any similar discharge ([Fig. S3*E*](#sup1){ref-type="supplementary-material"}). Notably, glutamine-induced changes were observed in FS-like but less so in IR-like cells (Fig. [5](#bhz055F5){ref-type="fig"}*F*), which is consistent with IR-like cells expressing alternative transport systems. Collectively, we suggest that glutamine can tonically excite FS interneurons, at least in isolation.

Deletion of Slc38a1 Alters Gamma Oscillations In vivo {#bhz055s20}
-----------------------------------------------------

Given that pharmacological probing of Slc38a1 alters interneuron activity and that maturation of PV^+^ FS neurons dictates onset of the enhanced plasticity period in early postnatal life ([@bhz055C24]), we next investigated if cortical processing and plasticity were also altered in the Slc38a1^−/−^*in vivo*. Extracellular recordings of single unit activity and local field potentials (LFP) from the primary visual cortex of anesthetised Slc38a1^−/−^ mice at the peak of the critical period (P29-31) revealed that oscillations in the gamma (ɣ) frequency band (30--90 Hz) were significantly slower compared to Slc38a1^+/+^ (Fig. [6](#bhz055F6){ref-type="fig"}*A*--*B*). Gamma activity is thought to be important for cognition and arises from synchronous activity of FS PV^+^ interneurons ([@bhz055C11]). The slower ɣ frequency of the Slc38a1^−/−^ resembles what has been found in immature PV^+^ network where there is also lower levels of GABA and which is characteristic of pre- critical period conditions ([@bhz055C24]; [@bhz055C2]).

![Slc38a1 inactivation alters population activity *in vivo*. (*A*) Examples of power spectra of LFP in Slc38a1^−/−^ (red) compared to Slc38a1^+/+^ control (black). The peak in the power spectrum of the local field potential was identified in the gamma range (30--90 Hz). (*B*) Gamma peak frequency was significantly lower in slc38a1^−/−^ mice (*n* = 10) compared to controls (*n* = 11) (Slc38a1^−/−^: 37 ± 1 Hz, wt: 44 ± 1 Hz,. Linear mixed model, \*p~genotype~ = 0.03). (*C*) Example waveforms of a broad-spiking putative excitatory unit (green) and narrow-spiking putative inhibitory unit (blue) (*D*) Spike waveform width plotted against peak-to-trough time for all units (*n* = 273) showing separate clustering of inhibitory units and excitatory units (filled circles: excitatory units; open circles: inhibitory units). Units were classified based on principal component analysis of waveform parameters. (*E*) Peristimulus histogram showing average firing rate of putative excitatory neurons in response to visual stimuli of both eyes. Stimulus onset at time 0 (gray line). (*F*) No difference in spontaneous firing rates of excitatory neurons between the genotypes (Slc38a1^−/−^: 1.7 ± 0.4 spikes/s versus Slc38a1^+/+^: 2.1 ± 0.4 spikes/s). The spontaneous activity of inhibitory units recorded from Slc38a1^−/−^ mice is significantly higher than that of Slc38a1^+/+^ (Slc38a1^−/−^: 3.1 ± 0.9 spikes/s versus Slc38a1^+/+^: 1.5 ± 0.4 spikes/s, generalized linear model, pgenotype:unit type = 0.04, comparisons of least square means, inhibitory units: Slc38a1^−/−^ vs. Slc38a1^+/+^: *P* = 0.009).](bhz055f06){#bhz055F6}

Deletion of Slc38a1 Alters the Activity of Visual Cortex Inhibitory Neurons {#bhz055s21}
---------------------------------------------------------------------------

To examine if Slc38a1 deletion affects neuronal activity on the single-cell level we recorded 282 single units from the primary visual cortex (109 units from Slc38a1^−/−^ (*N* = 11) and 173 from Slc38a1^+/+^ (*N* = 11)). Recorded units were classified as putatively excitatory (broad-spiking) or inhibitory (narrow-spiking) neurons based on spike waveform parameters ([@bhz055C1]) (Fig. [6](#bhz055F6){ref-type="fig"}*C*--*D*, [S4*A*](#sup1){ref-type="supplementary-material"}).

Both genotypes responded to visual stimuli (drifting gratings) (Fig. [6](#bhz055F6){ref-type="fig"}*E*), and firing rates of excitatory units were comparable between Slc38a1^−/−^ and Slc38a1^+/+^ (Slc38a1^−/−^: 1.7 ± 04 spikes/s versus Slc38a1^+/+^: 2.1 ± 0.4 spikes/s; Fig. [6](#bhz055F6){ref-type="fig"}*F*). In contrast, spontaneous activity of inhibitory units recorded in Slc38a1^−/−^ mice was significantly higher than that of Slc38a1^+/+^ (Slc38a1^−/−^: 3.1 ± 0.9 spikes/s versus Slc38a1^+/+^: 1.5 ± 0.4 spikes/s, generalized linear model, pgenotype:unit type = 0.04, comparisons of least square means, inhibitory units: Slc38a1^−/−^ vs. Slc38a1^+/+^: *P* = 0.009); Fig. [6](#bhz055F6){ref-type="fig"}*F*), while stimulus-evoked rates did not differ ([Fig. S5D](#sup1){ref-type="supplementary-material"}). The selective effect of Slc38a1 deletion on baseline activity of inhibitory neurons is consistent with impaired GABAergic neurotransmission and perturbed discharges in FS PV^+^ interneurons.

Visual cortex neurons respond with preference to stimuli consisting of high contrast lines of specific orientations. Response strength to the preferred orientation measured as orientation selectivity index (OSI) was not affected by Slc38a1 deletion in neither excitatory nor inhibitory units ([Fig. S4*B*--*C*](#sup1){ref-type="supplementary-material"}), suggesting that the Slc38a1 deletion does not influence basic responses to sensory stimulation.

Slc38a1 Deletion Impairs Ocular Dominance Plasticity {#bhz055s22}
----------------------------------------------------

Altered inhibitory neuron activity of Slc38a1^−/−^ resembles that of an immature neural network and could contribute to impaired cortical plasticity. To test this, we used the classical model of ocular dominance plasticity in the primary visual cortex ([@bhz055C36]). The majority of neurons in the binocular part of the primary visual cortex respond stronger to stimulation of the contralateral eye than the ipsilateral eye, a phenomenon called ocular dominance. If the dominant eye is deprived of adequate sensory input during the critical period, the population of binocular neurons will shift their preference towards the non-deprived eye ([@bhz055C27]). As deletion of Slc38a1 impairs GABAergic function, we posited that ocular dominance plasticity during the critical period is affected in Slc38a1^−/−^ mice. Activity-dependent plasticity was experimentally induced by MD for 4 days during the critical period. MD caused a shift in eye preference for excitatory units from the contralateral (deprived) towards the ipsilateral (non-deprived) eye, measured as a reduction in contralateral bias, but the shift was only significant for Slc38a1^+/+^ animals (Fig. [7](#bhz055F7){ref-type="fig"}*A*--*C*). Conversely, inhibitory neurons from Slc38a1^+/+^ displayed a shift towards preference for the contralateral (deprived) eye after MD, something which was not seen in Slc38a1^−/−^ animals (Fig. [7](#bhz055F7){ref-type="fig"}*D*--*F*).

![Altered ocular dominance plasticity in Slc38a1^−/−^ mice. Stimulus evoked firing rates of excitatory (*A*,*B*) and inhibitory (*D*,*E*) units in response to stimulation of contralateral (deprived) and ipsilateral (non-deprived) eyes with drifting gratings for slc38a1^−/−^ (red) and Slc38a1^+/+^ (black) animals exposed to 4 days monocular deprivation (MD) compared to untreated controls. For inhibitory units, Slc38a1^−/−^ had significantly higher contralateral eye evoked rates compared to Slc38a1^+/+^ (linear mixed model, p~genotype:unit\ type~ = 0.002; Comparison of least square means, p~IN:\ ko\ vs.\ wt~ = 0.008). Contralateral bias was calculated based on responses to contralateral vs. ipsilateral eye (C/(C + I)), with higher score indicating greater relative response to contralateral eye. (*C*) For excitatory units, monocular deprivation led to a shift to lower contralateral bias, however, on group level, this shift was only significant for Slc38a1^+/+^ animals (Slc38a1^−/−^: 0.495 ± 0.02, MD: 0.48 ± 0.02; Slc38a1^+/+^: 0.500 ± 0.012; MD: 0.43 ± 0.02, Linear mixed model, p~treatment~ = 0.04; p~genotype:treatment:unit\ type~ = 0.01; Comparison of least square means: p~EX:\ ko\ vs.\ wt~ = 0.01; p~EX,wt:control\ vs.\ MD~ = 0.004). F) For inhibitory units, monocular deprivation led to a shift towards higher contralateral bias in Slc38a1^+/+^ animals (0.45 ± 0.03, p~IN:\ wt:\ Control\ vs.\ wt~ = 0.02), while no such shift took place in Slc38a1^−/−^ animals (control: Slc38a1^−/−^: 0.50 ± 0.02; Slc38a1^+/+^:; MD: Slc38a1^−/−^: 0.52 ± 0.04; Slc38a1^+/+^: 0.59 ± 0.07, p~wt:\ IN:\ control\ vs.\ MD~ = 0.02).](bhz055f07){#bhz055F7}

MD significantly reduced the spontaneous firing rates of both Slc38a1^−/−^ and Slc38a1^+/+^ inhibitory neurons ([Fig. S5](#sup1){ref-type="supplementary-material"}). Despite their reduced activity, Slc38a1^−/−^ inhibitory units still showed higher spontaneous activity than Slc38a1^+/+^ after MD (S5C). Absence of a normal MD response in Slc38a1^−/−^ animals and the apparent reduction in stimulus-evoked rate of excitatory units after MD ([Fig. S5*B*](#sup1){ref-type="supplementary-material"}), resemble pre-critical period conditions ([@bhz055C50]). This suggests that deletion of Slc38a1 may contribute to render the cortical network in an immature state; unable to enter the critical period due to impaired GABA signaling. In this respect, Slc38a1 appears to be of fundamental importance for normal cortical development and GABA-dependent plasticity.

Discussion {#bhz055s23}
==========

We establish that Slc38a1 is enriched in PV^+^ interneurons and that Slc38a1 disruption has impact on synaptic vesicle size, vesicular load and GABAergic signaling (for summary of the results see [Fig. S6](#sup1){ref-type="supplementary-material"}). Slc38a1 drives FS cell activity, triggers AP generation and regulates network excitability. Genetic inactivation of Slc38a1 altered ocular dominance plasticity and γ oscillations suggesting impaired GABA signaling resembling neuronal networks in an immature state. Collectively, our data implicate that Slc38a1 contributes to normal cortical development and plasticity. Thus, dysfunctional glutamine supply and Slc38a1 activity may contribute to neurologic dysfunction such as in epilepsy, autism, schizophrenia and anxiety ([@bhz055C51]; [@bhz055C37]).

Slc38a1 Aids Interneurons to Replenish Neurotransmitter Pools of GABA {#bhz055s24}
---------------------------------------------------------------------

Slc38a1^−/−^ mice helped us to show that Slc38a1 is intrinsic to glutamine transport into GABAergic neurons to sustain GABA neurotransmitter pools: glutamine and aspartate, upstream and downstream metabolites of GABA, respectively, are selectively and significantly reduced in forebrain extracts and synaptosomal fractions. The significant reduction in aspartate in brain extracts and synaptosomes is indicative of a reduced influx of glutamine into the tricarboxylic acid (TCA) cycle of GABAergic neurons, leading to a reduced formation of TCA cycle end product, which equilibrates with aspartate. Our data agree with the notion that system A activity being responsible for 87% of neuronal uptake of glutamine ([@bhz055C33]). Furthermore, they corroborate glutamine as a major precursor for transmitter GABA synthesis, consistent with a large number of classical studies (e.g., [@bhz055C45]; [@bhz055C53]). Indeed, oral glutamine supplementation increases CNS levels of GABA ([@bhz055C56]).

As the reduction of glutamine and GABA in Slc38a1^−/−^ mice is significant yet they survive and process information properly, we suggest the existence of alternative pathways to maintain a certain level of vesicular GABA. In Slc38a1^−/−^ mice, GAT1 expression is preserved. This suggests that GABA re-uptake into nerve terminals maintains basic GABAergic activity and prevents mal-development and/or mal-function of the brain as described for GAT1^−/−^ mice ([@bhz055C29]). Key enzymes involved in GABA synthesis from glutamine (GAD67 and PAG) are significantly increased, and the preservation of GABA occurs at the expense of glutamine and glutamate. Tonic non-vesicular release of GABA from GABAergic neurons or astroglial cells, e.g., by the calcium-activated anion channel Bestrophin-1 ([@bhz055C58]; [@bhz055C59]; [@bhz055C51]) may also contribute to maintain GABAergic activity. Thus, Slc38a1 is intrinsic for GABA formation, with additional mechanisms existing to partly offset the metabolic drain that occurs in Slc38a1 ko animals.

Interestingly, Slc38a1 inactivation upregulates GAD67 but not GAD65. GAD65 is enriched in nerve terminals, functionally couples to VGAT on synaptic vesicle membranes to facilitate the generation and accumulation of GABA inside synaptic vesicles for phasic synaptic release ([@bhz055C31]). In contrast, GAD67 is shown to synthesize most GABA and is involved in generating GABA also for non-vesicular release and tonic firing ([@bhz055C9]). Interestingly, GAD67^−/−^ mice have significantly reduced brain GABA concentrations while GABA levels appear normal in GAD65^−/−^ ([@bhz055C51]). Our data are thus consistent with GAD67 activity being selectively regulated by GABA levels ([@bhz055C51]).

Slc38a1 Defines GABAergic Vesicular Dynamics and Content {#bhz055s25}
--------------------------------------------------------

Slc38a1 inactivation impacts synaptic vesicle biology in GABAergic neurons in 3 ways: (1) vesicle size is reduced, (2) vesicular GABA content is reduced, while (3) vesicle density is increased. Interestingly, many pre-synaptic factors have been identified to be involved in defining vesicular content by regulating vesicular filling and/or vesicular recycling ([@bhz055C18]). The vesicular loading of e.g., dopamine depends on extracellular concentrations of dopamine and on activation of tyrosine hydroxylase ([@bhz055C46]). We see reduced cytosolic concentrations of glutamate and glutamine in GABAergic neurons. Our data corroborate that vesicular GABA is in steady state with extra-vesicular glutamate concentration and that Slc38a1-mediated glutamine transport regulates GABAergic quantal size ([@bhz055C41]; [@bhz055C33]). The reduction in vesicle size may be due to reduced transmitter amount and shrunken vesicles, as a linear relationship has been demonstrated between quantal size and vesicular volume ([@bhz055C34]). Finally, the number of synaptic vesicles may have been increased to overcome reduced vesicular content and to sustain GABAergic neurotransmission. Alternatively, a reduction in the vesicular GABA content and dependence relatively more on re-uptake through GAT1 may have increased the pool of releasing vesicles that may be smaller in size ([@bhz055C54]). Altogether, our data demonstrate that Slc38a1 activity has impact on GABAergic vesicular content.

Deletion of Slc38a1 Alters Cortical Processing and Plasticity *In vivo* {#bhz055s26}
-----------------------------------------------------------------------

Activity of PV^+^ interneurons is sufficient to drive γ oscillations ([@bhz055C12]). Models of immature and mature PV^+^ inhibitory networks show a development of γ oscillations from low coherence and slower frequency in immature networks towards higher γ frequency oscillations of greater coherence in mature networks, reaching adult levels by the fourth week of life ([@bhz055C17]). Hence, the lower frequency γ oscillations in Slc38a1^−/−^ mice may reflect immaturity of PV^+^ inhibitory neurons. The higher firing activity observed in Slc38a1^−/−^ inhibitory neurons is in harmony with a compensation for lower GABA quantal size as inhibitory neurons in general and PV^+^ neurons in particular have strong self-inhibition ([@bhz055C47]). Such compensation may be insufficient as Slc38a1^−/−^ mice still show slower γ oscillations and altered activity dependent plasticity.

The PV^+^ inhibitory neurons are established as key players for critical period plasticity. In the visual cortex, this sub-class of inhibitory neurons matures at the time of the critical period and is assumed responsible for opening the period of plasticity. Impaired GABAergic synaptic transmission is therefore likely to affect refinement of cortical circuits. Slc38a1^−/−^ neurons have impaired ocular dominance plasticity in response to MD during the critical period compared to Slc38a1^+/+^ neurons. Our results are similar to those from GAD65^−/−^ mice, where impaired GABA release delays opening of the critical period for ocular dominance plasticity indefinitely ([@bhz055C19]), and MD has no discernable effect on ocular dominance of the visual cortex cells. This supports a role for Slc38a1 in GABA-dependent plasticity of the developing cortex.

Conclusions {#bhz055s27}
===========

Slc38a1 is intrinsic for the defining of the GABAergic vesicular load and a key regulator of normal cortical development and presynaptic inhibitory synaptic plasticity. As dysfunctional GABA metabolism and signaling has been associated with several neurological diseases such as in epilepsy, autism, schizophrenia and anxiety ([@bhz055C51]; [@bhz055C37]), dysfunctional Slc38a1 activity may play a role in their pathogenesis. Thus, further investigations are required to reveal potential contribution of Slc38a1 to pathophysiology.
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